Regafenib monohydrate is a type of hydrate that is a monohydrate form of anhydrous regafenib. Used to treat metastatic colorectal cancer in patients who have previously received chemotherapy, anti EGFR, or anti VEGF treatment. It has the effects of anti-tumor agents, tyrosine kinase inhibitors, and hepatotoxic agents. It contains Regfenib.